Cargando…
Targeting the metastatic niche: Single-cell lineage tracing in prime time
Identification of actionable drug targets remains a rate-limiting step of, and one of the most prominent barriers to successful drug development for metastatic cancers. CRISPR-Cas9, a tool for making targeted genomic edits, has given rise to various novel applications that have greatly accelerated d...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988656/ https://www.ncbi.nlm.nih.gov/pubmed/36895653 http://dx.doi.org/10.1016/j.isci.2023.106174 |